Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
These side effects may have compromised further development of the product [3]
Also tell your health care provider if you have stomach problems that will not go away
Tirzepatide is a glucose-dependent insulinotropic polypeptide/GLP- 1 dual receptor agonist (GIP/GLP- 1 RA) and in the Phase 3 SURMOUNT- 1 trial, tirzepatide 5 mg, 10 mg and 15 mg produced mean weight reduction from baseline to week 72 of 15,0%, 18.5% and 20.9%, respectively, versus 2.4% for placebo
In a rigorous 6-week, double-blind, placebo-controlled clinical trial published in the Aesthetic Surgery Journal Open Forum, DermaReverse demonstrated remarkable results among GLP-1 users: 100% of participants experienced an improvement in wrinkle appearance 100% experienced an improvement in surface roughness 100% experienced a reduction in redness 100% experienced an improvement in hydration 100% agreed DermaReverse was gentle enough for daily use These results were verified by independent board-certified plastic surgeons and third-party independent medical journal reviewers, establishing DermaReverse as not just another skincare product, but a clinically validated treatment specifically addressing the unique skin concerns of GLP-1 users
No supplements are not required
Antiviral Research
US$ 28.45
US$ 22.83
US$ 25.28
